LATENT TUBERCULOSIS
Clinical trials for LATENT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new LATENT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for LATENT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cash and cameras: new study fights TB by boosting treatment completion
Disease control Recruiting nowThis study tests whether offering small financial rewards and using video calls to watch people take their medicine can help more people finish treatment for latent tuberculosis. About 399 adults in Baltimore who are starting TB treatment will be split into groups: some get usual…
Matched conditions: LATENT TUBERCULOSIS
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
One-Month TB shield: Game-Changer for teens?
Prevention Recruiting nowThis study tests a new, ultra-short 1-month treatment to prevent tuberculosis (TB) in teenagers and school staff who have been exposed to someone with active TB. The goal is to see if the 1-month regimen is as effective as the standard 3-month treatment, while being easier to com…
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE3 • Sponsor: Huashan Hospital • Aim: Prevention
Last updated Jun 17, 2026 12:02 UTC
-
TB prevention breakthrough? 6-Week regimen could replace months of treatment
Prevention Recruiting nowThis study compares a new 6-week daily rifapentine regimen to the standard 12-16 week rifamycin-based treatment for latent tuberculosis infection (LTBI). The goal is to see if the shorter treatment is just as safe and effective at preventing active TB. About 3,400 people at highe…
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE2, PHASE3 • Sponsor: Centers for Disease Control and Prevention • Aim: Prevention
Last updated Jun 08, 2026 13:07 UTC
-
TB study aims to unlock secrets of the disease
Knowledge-focused Recruiting nowThis study follows 150 people with active or latent tuberculosis (TB) to collect blood, sputum, and tissue samples. The goal is to better understand how TB behaves in the body and how the immune system responds. Participants receive standard TB treatment as part of the study, but…
Matched conditions: LATENT TUBERCULOSIS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 23, 2026 22:17 UTC